Putrescine dihydrochloride

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePutrescine dihydrochloride
Drug Alias NamePutrescineFibrostat
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-glutamine gamma-glutamyltransferase inhibitors
TargetsProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsCicatrix, Hypertrophic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmbrilia Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Manitoba
Active IndicationsN/A
Inactive IndicationsCicatrix, Hypertrophic

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank